Products

PeraMobile and PeraWatch
PeraHealth (acquired by Spacelabs Healthcare)
Clinical Decision Support & Reference
PeraHealth, now part of Spacelabs Healthcare, offers predictive analytics solutions like PeraMobile and PeraWatch, powered by the FDA-cleared Rothman Index, to help healthcare providers identify at-risk patients sooner for earlier intervention, improve quality, and reduce costs.

See all 1 product →

About PeraHealth (acquired by Spacelabs Healthcare)

PeraHealth, now part of Spacelabs Healthcare, is a healthcare AI company renowned for its predictive analytics software, primarily the Rothman Index. This FDA-cleared solution quantifies patient acuity by analyzing over 50 measures, including vital signs and lab results, extracted from electronic health records (EHRs) in real-time. For physicians, the Rothman Index provides a visual dashboard of a patient’s condition, enabling early detection of deterioration. This capability is crucial for reducing in-hospital mortality, preventing unplanned transfers to the ICU, and facilitating more timely palliative care consultations.

The platform’s utility extends to various aspects of hospital operations and patient care. It assists healthcare providers in making informed decisions regarding patient discharge, prioritizing bedside visits and nursing assignments, improving documentation accuracy, optimizing ICU bed utilization, and identifying patients at risk for conditions like sepsis. The Rothman Index has been validated for use with neonatal, pediatric, and adult patients across different hospital settings, including emergency departments, general wards, and intensive care units. Its integration with major EHR vendors allows for comprehensive patient monitoring at the unit, hospital, and system levels.

Focus Areas

predictive analytics clinical surveillance patient deterioration patient acuity real-time data electronic health records (EHR) AI in healthcare clinical decision support

Business Intelligence

TechnologyMachine learning platform leveraging the Rothman Index algorithm, integrated with Electronic Health Records (EHRs)

What Physicians Need to Know

Predictive Analytics & Real-time Clinical Surveillance
PeraHealth specializes in real-time predictive analytics and clinical surveillance, utilizing the Rothman Index to quantify patient acuity and detect subtle patient deterioration hours or days earlier than traditional methods. This helps in proactive intervention and improved patient outcomes.
Patient Acuity & Deterioration
Their core technology, the Rothman Index, is an FDA-cleared predictive analytics solution that synthesizes vast amounts of real-time Electronic Medical Record (EMR) data, including vital signs, lab results, and nursing assessments, into a single, universal patient score (0-100). This score visually represents a patient's condition and trends over time, enabling early identification of at-risk patients.
Sepsis Detection
The Rothman Index assists with early prediction of sepsis by capturing physiological deterioration, allowing for timely intervention and a reduction in sepsis mortality. It aims to overcome limitations of other sepsis screening tools that may have limited effectiveness and high false-positive rates.
ICU Optimization & Transfers
PeraHealth's solutions help optimize ICU bed utilization, improve patient flow, and reduce unplanned transfers to the ICU by providing objective decision support to prioritize patients and identify those who may be safely discharged.
Palliative Care Consults
The Rothman Index can act as a trigger for palliative care interventions, helping to identify patients who could benefit from palliative care consults, potentially leading to decreased length of stay and reduced costs.
Reducing In-Hospital Mortality
By enabling earlier detection of patient deterioration and facilitating timely interventions, PeraHealth's solutions have been proven to reduce in-hospital mortality rates.
Clinical Decision Support & Data Technology Platform
PeraHealth provides an FDA-cleared clinical decision support platform that synthesizes EMR data into actionable insights for clinicians, supporting early warning, patient placement, transfer decisions, and discharge readiness. It is a SaaS-based HealthTech solution.
Physician Tip

PeraHealth's Rothman Index provides physicians with a real-time, easy-to-understand visual dashboard of a patient's condition, summarizing complex EHR data into a single, trended score. This allows for rapid assessment of patient acuity, early detection of subtle deterioration, and proactive intervention. It helps prioritize patient visits, optimize ICU bed use, and identify patients who may benefit from palliative care. The system integrates seamlessly into existing clinical workflows and can be accessed via EHRs, web browsers, or command-center views, empowering physicians with actionable insights to improve patient outcomes and operational efficiency.

PeraHealth's solutions are designed for seamless integration with major Electronic Health Record (EHR) vendors, including Epic, Cerner, and Meditech. They leverage APIs for integration, allowing hospitals to maximize their EHR investments and enable a seamless workflow for care teams. The Google Cloud-based version of the Rothman Index solution also includes full integration with Epic EMR systems.

Products by PeraHealth (acquired by Spacelabs Healthcare)

1 product in the directory

PeraMobile and PeraWatch
PeraHealth (acquired by Spacelabs Healthcare)
Clinical Decision Support & Reference
PeraHealth, now part of Spacelabs Healthcare, offers predictive analytics solutions like PeraMobile and PeraWatch, powered by the FDA-cleared Rothman Index, to help healthcare providers identify at-risk patients sooner for earlier intervention, improve quality, and reduce costs.

What the Web Says

PeraHealth, acquired by Spacelabs Healthcare in 2023, is known for its Rothman Index predictive analytics software, which helps clinicians identify patient deterioration. While the product itself is generally viewed positively for its ability to improve patient outcomes, employee reviews for the acquiring company, Spacelabs Healthcare, indicate significant concerns regarding management, company culture, and job security.

Overall: Mixed

Strengths

  • Great product (Rothman Index) that helps identify at-risk patients sooner and can lower mortality rates.
  • FDA-cleared predictive analytics solution.
  • Integrates with existing medical records data.
  • Potential to improve quality and reduce costs in healthcare.
  • Supportive colleagues and a small company/family feel within some teams at Spacelabs Healthcare.
  • Opportunities to learn medical devices at Spacelabs Healthcare.

Limitations

  • Poor company culture at PeraHealth prior to acquisition, with employees competing for advancement.
  • Lack of leadership, rewarding incompetence, and high turnover of quality people at Spacelabs Healthcare.
  • Inexperienced management with little compassion for employees at Spacelabs Healthcare.
  • Limited growth opportunities and low investment in R&D at Spacelabs Healthcare.
  • Frequent product failures and unresponsive sales/support at Spacelabs Healthcare.
  • Concerns about Spacelabs Healthcare being a "dying company" with misguided leadership.

Based on reviews from: Indeed.com, Zippia, DOTmed, Research Live, Spacelabs Healthcare (Press Release), Business Wire, Mainsail Partners, AVIA Marketplace, Reddit, MrWeb, Tracxn, G2, SimplyHired

Last updated: 2026-10-19

Videos

News, demos, and interviews about PeraHealth (acquired by Spacelabs Healthcare).

Loading videos...

Videos load interactively. If none appear, search YouTube for PeraHealth (acquired by Spacelabs Healthcare) →

View all on YouTube

Press & Coverage

Business Wire
Spacelabs Healthcare Expands Clinical Informatics Capabilities with Acquisition of Predictive Analytics Company PeraHealth
Spacelabs Healthcare announced its acquisition of PeraHealth, highlighting PeraHealth's predictive analytics software based on the Rothman Index to quantify patient acuity and improve outcomes.
2023-02
Healthcare Innovation
Spacelabs Buys Predictive Analytics Company PeraHealth
This article details Spacelabs Healthcare's acquisition of PeraHealth, emphasizing the Rothman Index's role in detecting patient decline and its use by major health systems.
2023-02
Dotmed.com
Spacelabs Healthcare acquires predictive analytics company PeraHealth
The acquisition of PeraHealth by Spacelabs Healthcare is covered, noting the Rothman Index's ability to alert clinicians to patient deterioration and reduce in-hospital mortality.
2023-02
MRWeb
Spacelabs Buys Predictive Analytics Firm PeraHealth
Report on Spacelabs Healthcare's acquisition of PeraHealth, mentioning the Rothman Index as an FDA-cleared predictive analytics solution that uses machine learning for actionable insights.
2023-03
Pharmaphorum
FDA clears PeraHealth's lifesaving clinical surveillance tech
PeraHealth's PeraTrend solution received 510(k) clearance from the FDA, making it the first of its kind to do so, and highlighting its use of the Rothman Index for real-time clinical surveillance.
2018-05
Business Wire
PeraHealth Appoints Joseph Beals as Chief Executive Officer
Joseph Beals was named CEO of PeraHealth, bringing extensive experience in applying analytical and informatics methods to healthcare.
2021-05
Becker's Hospital Review
PeraHealth Secures $14 Million in Funding from Mainsail Partners
PeraHealth received $14 million in funding from Mainsail Partners to expand its clinical surveillance solutions and support research and development.
2017-01
Forbes
The Rothman Index: A Human Perspective on Digital Health
This article discusses the origins of the Rothman Index, developed by the Rothman brothers after a personal tragedy, and its ability to synthesize EHR data into actionable information for clinicians.
2017-02

Frequently Asked Questions

PeraHealth's predictive analytics, primarily through the Rothman Index, aims to identify patient deterioration, detect sepsis early, and optimize ICU utilization. It integrates with existing EHR systems to pull real-time patient data, transforming it into actionable insights for clinicians. This helps in reducing unplanned ICU transfers and in-hospital mortality by providing a continuous, objective measure of patient acuity.
The real-time clinical surveillance system continuously monitors patient data and provides an objective measure of patient condition, such as the Rothman Index, which can alert care teams to potential deterioration. This early warning system empowers clinicians with data-driven insights, facilitating timely interventions and improving patient outcomes by enabling proactive care and reducing adverse events.
PeraHealth's solutions are built on a robust data technology platform delivered via a Software as a Service (SaaS) model, ensuring scalability and accessibility. The platform is designed to be highly secure and compliant with healthcare data regulations, including HIPAA, to protect sensitive patient information. This architecture allows for seamless updates and maintenance while providing a reliable and secure environment for clinical data analysis.
While specific pricing structures can vary based on the size and needs of the healthcare institution, PeraHealth's SaaS model typically involves subscription-based fees. Hospitals can expect comprehensive support during implementation, including integration with their existing systems and staff training. Ongoing support usually includes technical assistance, performance monitoring, and regular updates to ensure optimal system functionality and user satisfaction.
The acquisition by Spacelabs Healthcare is expected to enhance PeraHealth's market reach and product development, leveraging Spacelabs' resources and existing client base. This integration aims to strengthen the company's stability and accelerate innovation in predictive analytics and clinical surveillance. Future partnerships may be influenced by Spacelabs' strategic direction, potentially opening new avenues for collaboration and expanding the utility of PeraHealth's solutions within a broader healthcare technology ecosystem.

Related Companies

A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]

OpenAI is an American artificial intelligence (AI) company that conducts research and develops advanced AI models. While widely known for its generative AI models like ChatGPT and DALL-E, OpenAI has significantly expanded its focus into the healthcare sector. The company’s mission is to ensure that artificial general intelligence (AGI) benefits all of humanity, and this […]

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.